Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Faecal Microbiota Transplantation Reduces Lesion Severity and Medication Use in Canine Atopic Dermatitis: A Randomised, Placebo-Controlled, Double-Blinded Clinical Trial.

Veterinary dermatology·2026
Same author

Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial.

Inflammatory bowel diseases·2026
Same author

Reference Intervals for Serum Ferritin in Older Adults-Results from the Prospective SENIORLAB Study.

Journal of clinical medicine·2026
Same author

Diagnosis-independent contribution of low-grade inflammation to cortical atrophy across psychiatric disorders.

Brain, behavior, and immunity·2026
Same author

Playgrounds as microbial interfaces: strategies to enhance soil microbiomes and support healthy childhoods.

mSystems·2026
Same author

Climate change and allergic diseases: A scoping review.

The journal of climate change and health·2026

Related Experiment Video

Updated: Jul 4, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

The extrinsic coagulation activity assay.

Thomas W Stief1, Aleksandra Wieczerzak, Harald Renz

  • 1Department of Clinical Chemistry, Central Laboratory, University Hospital, Marburg, Germany. thstief@med.uni

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|July 1, 2008
PubMed
Summary
This summary is machine-generated.

A novel chromogenic assay accurately measures tissue factor-mediated thrombin generation. This extrinsic coagulation activity assay detects hypercoagulable states and is inhibited by common anticoagulants.

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jul 4, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Area of Science:

  • Biochemistry
  • Hematology
  • Clinical Chemistry

Background:

  • Thrombin generation is crucial for hemostasis.
  • Assessing the extrinsic coagulation pathway is vital for diagnosing bleeding or thrombotic disorders.
  • Existing assays may have limitations in accurately reflecting normal hemostasis or detecting specific pathway activation.

Purpose of the Study:

  • To develop and validate a chromogenic assay for quantifying thrombin generation via the extrinsic pathway.
  • To establish a reliable method for assessing extrinsic coagulation activity in plasma.
  • To evaluate the assay's performance in the presence of anticoagulants and varying fibrinogen levels.

Main Methods:

  • A chromogenic assay was developed using citrated plasma, tissue factor, albumin, and calcium chloride.
  • A 1-minute coagulation reaction time at 37°C was employed.
  • Hemostasis activation was terminated with arginine, followed by chromogenic quantification of generated thrombin.

Main Results:

  • The assay, termed extrinsic coagulation activity assay, demonstrated a normal range of 100% ± 20%.
  • Plasma from patients on heparin or coumarin anticoagulants showed approximately a 10-fold lower result.
  • The assay is not artifactually altered by fibrinogen/fibrin concentration and is minimally affected by plasma matrix changes.

Conclusions:

  • The extrinsic coagulation activity assay accurately represents normal extrinsic hemostasis.
  • The assay can identify patients with a hyper-activated extrinsic pathway.
  • The assay's results are unaffected by common anticoagulants and can be measured using standard photometers.